查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024426

龐貝氏症治療市場規模：治療方法、給藥途徑、通路、適應症類型及地區分類（2026-2034 年）

Pompe Disease Treatment Market Size by Treatment, Route of Administration, Distribution Channel, Indication Type, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球龐貝氏症治療市場規模達11億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到14億美元，2026年至2034年的複合年成長率為2.37%。臨床研究的增加和酵素替代療法（ERT）的日益普及是推動市場成長的主要因素。

龐貝氏症是一種遺傳性疾病，由體內細胞內一種名為肝醣的複雜醣原的累積所引起，影響器官、組織和肌肉。它是一種體染色體隱性遺傳的糖原貯積症，由溶酶體酶酸性α-Glucosidase（GAA）缺乏所引起。此病常伴隨肌肉無力、肝腫大、呼吸困難、聽力障礙、肺部感染疾病、心律不整和體重減輕等症狀。診斷涉及多種檢查和技術，包括圖、X光檢查和磁振造影（MRI）。龐貝氏症的治療方法包括藥物治療、酵素替代療法（ERT）、基材減少療法（SRT）、Chaperone增強替代療法（CART）和注射治療，所有這些療法都有助於改善患者的生活品質。

龐貝氏症治療市場趨勢：

個體中遺傳異常的盛行率顯著上升，導致龐貝氏症患者人數增加。此外，嬰兒龐貝氏症發病率的上升以及父母對新生兒健康日益成長的擔憂，也是推動市場成長的主要因素。老年人口的成長，尤其是老年人更容易患上此類疾病，也推動了對龐貝氏症治療的需求。為開發龐貝氏症新治療方法而進行的臨床研究和臨床實驗的增加，也對市場產生了正面影響。此外，大眾對酵素替代療法（ERT）作為龐貝氏症治療方法的認知度提高，也促進了市場成長。同時，由於幹細胞移植、骨髓移植、化療和免疫療法等多種治療方法，人們對它們的了解也不斷提高。此外，人們認知到ERT療法的替代療法（例如Lumizyme）已廣泛應用，這些因素共同為市場帶來了良好的前景。此外，健康保險的參保率不斷提高，為龐貝氏症治療提供了經濟支持，並降低了醫療成本。此外，許多政府和非政府組織正在採取措施，提供人人都能獲得的高品質醫療保健設施。同時，診斷技術的顯著進步預計將為市場帶來良好的前景。

本報告解答的主要問題

  • 龐貝氏症治療市場規模有多大？
  • 龐貝氏症治療市場的未來前景如何？
  • 推動龐貝氏症治療市場發展的主要因素是什麼？
  • 龐貝氏症治療市場中，哪個地區佔最大的市場佔有率？
  • 全球龐貝氏症治療市場的主要參與者有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球龐貝氏症治療市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依治療方法分類

  • 酵素替代療法（ERT）
  • 基材減少療法（SRT）
  • Chaperone高級替代療法 (CART)
  • 其他

第7章 市場區隔：依給藥途徑

  • 口服
  • 靜脈
  • 其他

第8章 市場區隔：依分銷通路分類

  • 醫院和診所藥房
  • 零售藥房
  • 網路藥房
  • 其他

第9章 市場區隔：依適應症類型分類

  • 嬰兒型龐貝氏症（IOPD）
  • 典型嬰兒類型
  • 非典型嬰兒型
  • 晚髮型龐貝氏症（LOPD）
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Amicus Therapeutics Inc.
    • Audentes Therapeutics Inc.（Astellas US Holding Inc.）
    • Oxyrane UK Limited
    • Sanofi SA
    • Spark Therapeutics Inc.
Product Code: SR112026A6708

The global Pompe disease treatment market size reached USD 1.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1.4 Billion by 2034, exhibiting a growth rate (CAGR) of 2.37% during 2026-2034. The increasing number of clinical research and the growing popularity of enzyme replacement therapy (ERT) are stimulating the market.

Pompe disease is a genetic disorder caused by the buildup of a complex sugar known as glycogen in the cells of the body, which affects organs, tissues, and muscles. It is an autosomal recessive glycogen storage syndrome caused by the deficiency of lysosomal enzyme acid a-glucosidase (GAA). It is associated with weak muscles, enlarged liver, trouble breathing, hearing problem, lung infection, irregular heartbeat, and losing weight. It is diagnosed using various tools and tests, including electromyography, X-rays, and magnetic resonance imaging (MRI). Pompe disease can be treated using medications, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), chaperone-advanced replacement therapy (CART), and injections, which aid in improving the quality of life.

Pompe Disease Treatment Market Trends:

There is a considerable rise in the prevalence of genetic abnormalities among individuals and an increase in the number of patients suffering from Pompe disease. This, coupled with the growing Pompe disease among infants and increasing concerns among parents about the health of their newborns, represents one of the key factors bolstering the growth of the market. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is resulting in an increasing demand for Pompe disease treatment. In addition, the expanding number of clinical studies and trials to develop new treatments for Pompe disease is influencing the market positively. Apart from this, the rising awareness among people about ERT for curing Pompe disease is favoring the market growth. Furthermore, there is an increase in awareness about various treatments, including stem cell transplant, bone marrow transplantation, chemotherapy, and immunotherapy, on account of their numerous advantages. This, along with the awareness about the easy availability of ERT treatment alternatives like lumizyme, is creating a positive outlook for the market. Besides this, there is a rise in the adoption of health insurance policies that provide financial assistance and minimize healthcare expenditure for Pompe disease treatment. Additionally, governments and non-governmental organizations (NGOs) of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is anticipated to provide a favorable outlook to the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with the market forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on treatment, route of administration, distribution channel, and indication type.

Treatment Insights:

  • Enzyme Replacement Therapy (ERT)
  • Substrate Reduction Therapy (SRT)
  • Chaperone-Advanced Replacement Therapy (CART)
  • Others

Route of Administration Insights:

  • Oral
  • Intravenous
  • Others

Distribution Channel Insights:

  • Hospital and Clinics Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Indication Type Insights:

  • Infantile-Onset Pompe Disease (IOPD)
  • Classic Infantile Form
  • Non-Classic Infantile Form
  • Late-Onset Pompe Disease (LOPD)
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Pompe disease treatment. Some of the factors driving the North America Pompe disease treatment market included the growing awareness about various alternative treatments, increasing number of clinical studies and trials, and well-established healthcare facilities.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global Pompe disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amicus Therapeutics Inc., Audentes Therapeutics Inc. (Astellas US Holding Inc.), Oxyrane UK Limited, Sanofi S.A., Spark Therapeutics Inc, etc.

Key Questions Answered in This Report

  • How big is the pompe disease treatment market?
  • What is the future outlook of pompe disease treatment market?
  • What are the key factors driving the pompe disease treatment market?
  • Which region accounts for the largest pompe disease treatment market share?
  • Which are the leading companies in the global pompe disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pompe Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment

  • 6.1 Enzyme Replacement Therapy (ERT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Substrate Reduction Therapy (SRT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Chaperone-Advanced Replacement Therapy (CART)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital & Clinics Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Indication Type

  • 9.1 Infantile-Onset Pompe Disease (IOPD)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Classic Infantile Form
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Non-Classic Infantile Form
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Late-Onset Pompe Disease (LOPD)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Amicus Therapeutics Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Audentes Therapeutics Inc. (Astellas US Holding Inc.)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Oxyrane UK Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Sanofi S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Spark Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio

List of Figures

  • Figure 1: Global: Pompe Disease Treatment Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Pompe Disease Treatment Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Pompe Disease Treatment Market: Breakup by Treatment (in %), 2025
  • Figure 4: Global: Pompe Disease Treatment Market: Breakup by Route of Administration (in %), 2025
  • Figure 5: Global: Pompe Disease Treatment Market: Breakup by Distribution Channel (in %), 2025
  • Figure 6: Global: Pompe Disease Treatment Market: Breakup by Indication Type (in %), 2025
  • Figure 7: Global: Pompe Disease Treatment Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Pompe Disease Treatment (Enzyme Replacement Therapy (ERT)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Pompe Disease Treatment (Enzyme Replacement Therapy (ERT)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Pompe Disease Treatment (Substrate Reduction Therapy (SRT)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Pompe Disease Treatment (Substrate Reduction Therapy (SRT)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Pompe Disease Treatment (Chaperone-Advanced Replacement Therapy (CART)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Pompe Disease Treatment (Chaperone-Advanced Replacement Therapy (CART)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Pompe Disease Treatment (Other Treatments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Pompe Disease Treatment (Other Treatments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Pompe Disease Treatment (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Pompe Disease Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Pompe Disease Treatment (Intravenous) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Pompe Disease Treatment (Intravenous) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Pompe Disease Treatment (Other Rout of Administrations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Pompe Disease Treatment (Other Rout of Administrations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Pompe Disease Treatment (Hospital & Clinics Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Pompe Disease Treatment (Hospital & Clinics Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Pompe Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Pompe Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Pompe Disease Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Pompe Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Pompe Disease Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Pompe Disease Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Pompe Disease Treatment (Infantile-Onset Pompe Disease (IOPD)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Pompe Disease Treatment (Infantile-Onset Pompe Disease (IOPD)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Pompe Disease Treatment (Classic Infantile Form) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Pompe Disease Treatment (Classic Infantile Form) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Pompe Disease Treatment (Non-Classic Infantile Form) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Pompe Disease Treatment (Non-Classic Infantile Form) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Pompe Disease Treatment (Late-Onset Pompe Disease (LOPD)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Pompe Disease Treatment (Late-Onset Pompe Disease (LOPD)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Pompe Disease Treatment (Other Indication Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Pompe Disease Treatment (Other Indication Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia-Pacific: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia-Pacific: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Pompe Disease Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Pompe Disease Treatment Market: Breakup by Country (in %), 2025
  • Figure 88: Middle East and Africa: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Pompe Disease Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Pompe Disease Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Pompe Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pompe Disease Treatment Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Pompe Disease Treatment Market Forecast: Breakup by Treatment (in Million USD), 2026-2034
  • Table 3: Global: Pompe Disease Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 4: Global: Pompe Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Pompe Disease Treatment Market Forecast: Breakup by Indication Type (in Million USD), 2026-2034
  • Table 6: Global: Pompe Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Pompe Disease Treatment Market: Competitive Structure
  • Table 8: Global: Pompe Disease Treatment Market: Key Players